Esig, Narisa N.
HRN: 23-90-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/17/2023
10/23/2023
IV
2.25
Q6
Sepsis; AGE With Severe Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose